Tempus AI, Inc.

Tempus AI, Inc. (TEM) priced its initial public offering on Jun 17, 2024 at $37.00 per share, within its $35.00–$37.00 range, raising $410.7M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $6.1B. J.P. Morgan was lead-left underwriter, joined by Allen & Company. Cooley advised the company and Davis Polk advised the underwriters.

Tempus AI, Inc. applies artificial intelligence to precision medicine, creating what it calls Intelligent Diagnostics that connect laboratory test results to a patient's clinical data. Its Tempus Platform draws on a large library of clinical and molecular oncology data.

Status

IPO

Ticker

TEM

Exchange

Nasdaq Global Select

Priced

Jun 17, 2024

IPO price

$37.00

Price range

$35.00–$37.00

Raised

$410.7M

Market cap at IPO price

$6.1B

First filed

May 20, 2024

Underwriters

J.P. Morgan and Allen & Company

Company counsel

Cooley

Underwriters' counsel

Davis Polk

Sector

Technology

Country / state

IL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.